** Shares of ImpediMed IPD.AX rise 5% to A$0.0525
** Stock set for best session since December 9, 2024, if gains hold
** The medical technology co's unit executes an agreement for a five-year $15 million growth capital facility with SWK Funding
** Co adds that funds raised will be used to support growth and commercialisation activities
** Stock down 3.9% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.